or Try an Advanced Search...

    Urological Disorders Stocks List

    Symbol Grade Name % Change
    EDAP B EDAP TMS S.A. -3.13
    ADXN C Addex Therapeutics Ltd -4.73
    RLMD D Relmada Therapeutics, Inc. -8.12
    MYO D Myomo Inc. 3.68
    OVID D Ovid Therapeutics Inc. 3.22
    HRMY D Harmony Biosciences Holdings, Inc. -0.55
    ENZ F Enzo Biochem, Inc. -1.74
    ACAD F ACADIA Pharmaceuticals Inc. -0.70
    FLGT F Fulgent Genetics, Inc. 0.10
    AEMD F Aethlon Medical, Inc. -0.35
    View As Page of Charts
    Related Industries: Biotechnology Diagnostics & Research Drug Manufacturers - Specialty & Generic Medical Devices Scientific & Technical Instruments
    Related Stock Lists: Neurological Disorders Biology Biopharmaceutical Biotechnology Cancer Medicine Cardiovascular Disease Organ Systems Rare Neurological Disorders Acid Algorithms Allosteric Regulation Alzheimer's Disease Amyotrophic Lateral Sclerosis Antibodies Anticonvulsants Antiviral Drug Applied Genetics Autoimmune Disease Biochemistry

    Related ETFs - A few ETFs which own one or more of the above listed Urological Disorders stocks.

    Symbol Grade Name Weight
    PSIL F AdvisorShares Psychedelics ETF 4.56
    AWEG C Alger Weatherbie Enduring Growth ETF 3.91
    IBRN D iShares Neuroscience and Healthcare ETF 3.33
    BBP D BioShares Biotechnology Products Fund 3.1
    FBT D First Trust Amex Biotech Index Fund 2.08
    View all Urological Disorders ETFs...
    Compare ETFs
    Compare AWEG to BBP Compare AWEG to FBT Compare PSIL to BBP

        Urological Disorders Stocks Recent News

        Date Stock Title
        Apr 18 ADXN Addex Therapeutics Ltd (ADXN) Q4 2023 Earnings Call Transcript
        Apr 18 ADXN Earnings Scheduled For April 18, 2024
        Apr 18 OVID We Think Ovid Therapeutics (NASDAQ:OVID) Can Afford To Drive Business Growth
        Apr 18 ADXN Addex Therapeutics GAAP EPS of -CHF 0.14, revenue of CHF 1.65M
        Apr 18 ADXN Addex Therapeutics Reports Full Year 2023 Financial Results and Provides Corporate Update
        Apr 17 ACAD Acadia Pharmaceuticals Presents New DAYBUE™ (trofinetide) Clinical Data at the 2024 American Academy of Neurology (AAN) Annual Meeting
        Apr 16 HRMY HARMONY BIOSCIENCES TO REPORT FIRST QUARTER 2024 FINANCIAL RESULTS ON APRIL 30, 2024
        Related Industries: Biotechnology Diagnostics & Research Drug Manufacturers - Specialty & Generic Medical Devices Scientific & Technical Instruments
        Related Stock Lists: Neurological Disorders Biology Biopharmaceutical Biotechnology Cancer Medicine Cardiovascular Disease Organ Systems Rare Neurological Disorders Acid Algorithms Allosteric Regulation Alzheimer's Disease Amyotrophic Lateral Sclerosis Antibodies Anticonvulsants Antiviral Drug Applied Genetics Autoimmune Disease Biochemistry
        Urological Disorders

        Urological disorders are conditions that affect the urinary tract and the organs of the reproductive system. These disorders can range from minor issues such as urinary tract infections to more serious conditions such as kidney stones, prostate cancer, and bladder cancer. Treatment for urological disorders can include medications, lifestyle changes, and in some cases, surgery.

        Browse All Tags